IRLAB participates in Pareto Securities’ 15th Annual Healthcare Conference

Gothenburg, Sweden, September 13, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will give a presentation at the event Pareto Securities’ 15th Annual Healthcare Conference, in Stockholm on September 19, 2024.

IRLAB participates in the event Investing in life science: From seed to success

IRLAB is granted additional patent for drug candidate mesdopetam that expands its patent protection